Advertisement

4 Reasons to Avoid the GoodRx IPO

4 Reasons to Avoid the GoodRx IPO

Initial public offerings from consumer-focused digital healthcare platforms have been terrific sources of gains for investors in 2020, and there's another big one on the way. Shares of GoodRx (NASDAQ:GDRX) are expected to begin trading soon, and plenty of everyday investors find the company's prospectus compelling. Digital coupons that route sales of prescription drugs through a pharmacy benefit manager (PBM) are increasingly popular.